Dr. Andrew Zhu Joins Chemokine Therapeutics' Clinical Advisory Board
Dr. Andrew Zhu is an attending oncologist as well as the director of Liver Cancer Research at Massachusetts General Hospital Cancer Center. He is also a staff physician at Dana-Farber Cancer Institute, and a member of Dana-Farber Harvard Cancer Center in Boston, Massachusetts. Dr. Zhu is an assistant professor of medicine at Harvard Medical School and is board-certified in internal medicine and medical oncology, and holds clinical research interests in developing novel treatments for gastrointestinal cancers including hepatocellular carcinoma, bile duct tumor and colorectal cancer.
Dr. Zhu earned his medical degree from Beijing Medical University in Beijing, China. He went on to study microbiology and obtain his Ph.D. at Columbia University in New York City, New York. Dr. Zhu finished his residency at Yale-New Haven Hospital, Yale School of Medicine in New Haven Connecticut and his fellowship in medical oncology and hematology at the Memorial Sloan-Kettering Cancer Center in New York City, Center, New York.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.